Beta: Sign in
Shares outstandingAs of 2026-08-17 · filed common shares: 3.06M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 17.64%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 5.68%
Short ratioDays to cover, as published by FINRA: 1.00
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 55.10%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 59.50%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross marginTTM to Jun 26: -90.64%
Operating marginTTM to Jun 26: -875.75%
Net margin: —
EBITDA marginTTM to Jun 26: -846.84%
Return on equity: —
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: -202.97%

Growth

Revenue growth (annual YoY): 28.73%
Revenue growth (latest qtr YoY): -77.15%
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, TTM to Jun 26

21.77

EPS (fwd)

Financial health

Cash & equivalentsas of Jun 26: $2.45M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $32.66M
Debt / equityas of Jun 26: -167.45%
Current ratioas of Jun 26: 0.14
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 0.09
Operating cash flowTTM to Jun 26: -$13.73M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: -$13.73M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 0.09

MEDS stock Statistics — DataMeds AI, Inc. filings, insiders & smart money · Instaport